Detalhe da pesquisa
1.
Predictive factors and oncological outcomes of pathological T3a upstaging in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy.
Jpn J Clin Oncol
; 54(2): 160-166, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37840320
2.
Real-world outcomes of nivolumab plus ipilimumab combination therapy for advanced renal cell carcinoma in Japanese patients: data with a minimum of 3 years of follow-up.
Jpn J Clin Oncol
; 54(5): 577-583, 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38251783
3.
First-line dual immune checkpoint inhibitor therapies versus combination therapies comprising immune checkpoint inhibitors and tyrosine kinase inhibitors for advanced renal cell carcinoma: a comparative analysis of the effectiveness using real-world data.
Int J Clin Oncol
; 29(4): 473-480, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38345708
4.
Renal cell carcinoma outcomes in end-stage renal disease: A 40-year study from two Japanese institutions.
Int J Urol
; 31(1): 73-81, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37798866
5.
Surgical and functional outcomes of repeat robot-assisted laparoscopic partial nephrectomy compared with repeat open partial nephrectomy.
Int J Urol
; 31(4): 355-361, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38146740
6.
Real-world efficacy and safety of cabozantinib following immune checkpoint inhibitor failure in Japanese patients with advanced renal cell carcinoma.
Jpn J Clin Oncol
; 53(10): 977-983, 2023 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37519060
7.
Impact of sex on prognosis in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitors.
Jpn J Clin Oncol
; 53(7): 611-618, 2023 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37002188
8.
Association between lung immune prognostic index and survival of patients with metastatic urothelial carcinoma treated with pembrolizumab.
Int J Clin Oncol
; 28(7): 913-921, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37103730
9.
Outcomes of nivolumab monotherapy for previously treated metastatic renal cell carcinoma: a real-world multi-institution data with a minimum of 2 years of follow-up.
Jpn J Clin Oncol
; 52(7): 785-790, 2022 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35373823
10.
Therapeutic role of deferred cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab.
Jpn J Clin Oncol
; 52(10): 1208-1214, 2022 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35780441
11.
C-reactive protein kinetics to predict recurrence of high-risk renal cell carcinoma after radical surgery.
Int J Clin Oncol
; 27(5): 969-976, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35150349
12.
Surgical and functional outcomes of robot-assisted laparoscopic partial nephrectomy for renal cell carcinoma in adolescents and young adults: a propensity score matching study.
Int J Clin Oncol
; 27(10): 1624-1631, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35877053
13.
Prognostic Impact of Trial-Eligibility Criteria in Patients with Metastatic Renal Cell Carcinoma.
Urol Int
; 106(4): 368-375, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34515259
14.
Clinical Effects of Early and Short-Term Tolvaptan Administration in Patients Hospitalized for Acute Decompensated Heart Failure.
Cardiology
; 146(6): 739-747, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34348260
15.
Assessing improvements in metastatic renal cell carcinoma systemic treatments from the pre-cytokine to the immune checkpoint inhibitor eras: a retrospective analysis of real-world data.
Jpn J Clin Oncol
; 51(5): 793-801, 2021 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33324983
16.
Hypopituitarism in patients with metastatic renal cell carcinoma treated with ipilimumab and nivolumab combination therapy.
Jpn J Clin Oncol
; 51(12): 1744-1750, 2021 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34487184
17.
Impact of sarcopenia on post-operative outcomes following nephrectomy and tumor thrombectomy for renal cell carcinoma with inferior vena cava thrombus.
Jpn J Clin Oncol
; 51(5): 819-825, 2021 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33558883
18.
Modest efficacy of nivolumab plus ipilimumab in patients with papillary renal cell carcinoma.
Jpn J Clin Oncol
; 51(4): 646-653, 2021 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33212488
19.
Prognostic impact of systemic therapy change in metastatic renal cell carcinoma treated with cytoreductive nephrectomy.
Jpn J Clin Oncol
; 51(2): 296-304, 2021 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32989464
20.
Association of tumor burden with outcome in first-line therapy with nivolumab plus ipilimumab for previously untreated metastatic renal cell carcinoma.
Jpn J Clin Oncol
; 51(12): 1751-1756, 2021 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34492101